Stay updated on EAP Avapritinib in Advanced GIST Clinical Trial
Sign up to get notified when there's something new on the EAP Avapritinib in Advanced GIST Clinical Trial page.

Latest updates to the EAP Avapritinib in Advanced GIST Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows a revision update from v3.2.0 to v3.3.2. This change does not affect the study content or its presentation.SummaryDifference0.1%

- Check21 days agoChange DetectedRemoved the government funding and operating status notice from the page (including references to cc.nih.gov and opm.gov). This does not affect the displayed study details or eligibility information.SummaryDifference0.6%

- Check35 days agoChange DetectedThe new screenshot shows only cosmetic UI/layout updates and does not modify core study information (title, NCT number NCT03862885, condition GIST, Avapritinib dosing, eligibility criteria, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference6%

- Check71 days agoChange DetectedUpdate reflects a new software version (v3.1.0) replacing the old v3.0.2; the page now references the new revision and no longer mentions the previous version.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page revision was updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.SummaryDifference0.4%

Stay in the know with updates to EAP Avapritinib in Advanced GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EAP Avapritinib in Advanced GIST Clinical Trial page.